Passage Bio, Inc.
Passage Bio, Inc.（PASG）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
pasg · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$15.00
Consensus
$10.00
+82.8% upside
Low
$7.00
Median: $8 · Last Close: $5.47
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$10.00
82.8% upside
High Target
$15
174.2%
Low Target
$7
28.0%
Current Price
$5.47
as of today
Based on analyst price targets, the PASG stock price prediction for the next 12 months ranges from $7 to $15. The consensus PASG price forecast of $10.00 implies 82.8% upside from the current price of $5.47.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $5.72 | ↑ 4.48% |
1-day model range: $5.67–$5.77. Peak: $5.77 (+4.48%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PASG · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-21 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-04-21 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2026-04-21 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2026-04-21 | Chardan Capital | Downgrade ↓ | Buy→Neutral |
| 2026-03-04 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-11-12 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-14 | Guggenheim | Maintains | Buy→Buy |
| 2025-08-14 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-13 | Wedbush | Maintains | Outperform→Outperform |
| 2025-06-24 | Chardan Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Passage Bio, Inc. (PASG) stock. Of the recent 40 rating actions, 2 were upgrades and 7 were downgrades. 11 analysts currently cover PASG.
分析师推荐趋势
PASG analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↓ 93.7% YoY
Revenue Next Year
$45M
↑ 2150.6% YoY
EPS This Year
$-9.21
EPS Next Year
$-7.84
↓ 14.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast PASG EPS of $-9.21 for the current fiscal year, based on estimates from 3 analysts. The PASG revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PASG 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PASG 的共识目标价为 $10.00（+82.8% 上行空间），分析师共识为 Buy。
PASG 的短期预测（明日）为 $5.72（+4.48%）。
Passage Bio, Inc. 在 NASDAQ 上市，代码 PASG。PASG 在 2027 年的整体展望偏积极，在覆盖分析师中约 55% 对应 Buy 共识。
常见问题
PASG 预测 · 8 个问题根据 11 位华尔街分析师，PASG 的 12 个月平均目标价为 $10.00，最高 $15.00、最低 $7.00。若有图表，中位目标价可在上方查看。相对当前价 $5.47，隐含约 +82.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.